Sensus Healthcare (SRTS) Proxy filing summary

Executive summary

• The annual meeting is scheduled for May 29, 2026, with proxy materials distributed to shareholders of record as of April 10, 2026.

• Key items include election of two Class II directors, advisory approval of executive compensation, and ratification of the independent auditor.

• The proxy statement is accompanied by the 2025 Annual Report, including audited financials and management's discussion.

Voting matters and shareholder proposals

• Shareholders will vote on electing two Class II directors for three-year terms, a say-on-pay advisory vote, and ratification of Carr, Riggs & Ingram, LLC as auditor for 2026.

• Shareholders may submit proposals for the 2027 meeting by January 1, 2027, and director nominations between January 29 and February 28, 2027.

• Voting can be done online, by phone, mail, or in person at the meeting.

Board of directors and corporate governance

• The board consists of six members divided into three classes, with staggered three-year terms.

• Four directors are independent per Nasdaq standards; two are not independent.

• Committees include Audit, Compensation, and Corporate Governance/Nominating, each with defined oversight roles.

• The board held eight meetings in 2025, with high attendance.

• A code of ethics and business conduct applies to all directors, officers, and employees.